Use of 11F-fluorothymidine positron emission tomography in brain tumor

Nobuyuki Kawai, Masahiro Kagawa, Keisuke Miyake, Yoshihiro Nishiyama, Yuka Yamamoto, Hirotoshi Shiraishi, Tomotsugu Ichikawa, Takashi Tamiya

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Positron emission tomography (PET) with [ 18F]-fluoro-3′- deoxy-3′-L-fluoro-thymidine (FLT) provides information on cellular proliferation activity and has been used in malignant brain tumors. FLT-PET is sensitive in detecting malignant glioma due to the very low background uptake in the normal brain tissue. However, the ability to detect low grade glioma and tumor extension appears to be lower for FLT than for methionine (MET). Recent studies have found a correlation between WHO tumor grade and FLT uptake in gliomas. Our recent experience demonstrated a significant difference in the maximum standardized uptake value (SUVmax) of FLT between grade II (0.27±0.06, n=6) and grade IV (2.18±0.93, n=10) glioma (P

Original languageEnglish
Pages (from-to)657-664
Number of pages8
JournalNeurological Surgery
Volume37
Issue number7
Publication statusPublished - Jul 2009

Fingerprint

Brain Neoplasms
Positron-Emission Tomography
Thymidine
Glioma
Methionine
Neoplasms
Cell Proliferation
Brain

Keywords

  • Brain tumor
  • Cell proliferation
  • FLT ([ F]-fluoro-3′-deoxy- 3′-L-fluoro-thymidine)
  • Glioma
  • Positron emission tomography

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Kawai, N., Kagawa, M., Miyake, K., Nishiyama, Y., Yamamoto, Y., Shiraishi, H., ... Tamiya, T. (2009). Use of 11F-fluorothymidine positron emission tomography in brain tumor. Neurological Surgery, 37(7), 657-664.

Use of 11F-fluorothymidine positron emission tomography in brain tumor. / Kawai, Nobuyuki; Kagawa, Masahiro; Miyake, Keisuke; Nishiyama, Yoshihiro; Yamamoto, Yuka; Shiraishi, Hirotoshi; Ichikawa, Tomotsugu; Tamiya, Takashi.

In: Neurological Surgery, Vol. 37, No. 7, 07.2009, p. 657-664.

Research output: Contribution to journalArticle

Kawai, N, Kagawa, M, Miyake, K, Nishiyama, Y, Yamamoto, Y, Shiraishi, H, Ichikawa, T & Tamiya, T 2009, 'Use of 11F-fluorothymidine positron emission tomography in brain tumor', Neurological Surgery, vol. 37, no. 7, pp. 657-664.
Kawai N, Kagawa M, Miyake K, Nishiyama Y, Yamamoto Y, Shiraishi H et al. Use of 11F-fluorothymidine positron emission tomography in brain tumor. Neurological Surgery. 2009 Jul;37(7):657-664.
Kawai, Nobuyuki ; Kagawa, Masahiro ; Miyake, Keisuke ; Nishiyama, Yoshihiro ; Yamamoto, Yuka ; Shiraishi, Hirotoshi ; Ichikawa, Tomotsugu ; Tamiya, Takashi. / Use of 11F-fluorothymidine positron emission tomography in brain tumor. In: Neurological Surgery. 2009 ; Vol. 37, No. 7. pp. 657-664.
@article{50534d98182d4a26ba30d47c62588146,
title = "Use of 11F-fluorothymidine positron emission tomography in brain tumor",
abstract = "Positron emission tomography (PET) with [ 18F]-fluoro-3′- deoxy-3′-L-fluoro-thymidine (FLT) provides information on cellular proliferation activity and has been used in malignant brain tumors. FLT-PET is sensitive in detecting malignant glioma due to the very low background uptake in the normal brain tissue. However, the ability to detect low grade glioma and tumor extension appears to be lower for FLT than for methionine (MET). Recent studies have found a correlation between WHO tumor grade and FLT uptake in gliomas. Our recent experience demonstrated a significant difference in the maximum standardized uptake value (SUVmax) of FLT between grade II (0.27±0.06, n=6) and grade IV (2.18±0.93, n=10) glioma (P",
keywords = "Brain tumor, Cell proliferation, FLT ([ F]-fluoro-3′-deoxy- 3′-L-fluoro-thymidine), Glioma, Positron emission tomography",
author = "Nobuyuki Kawai and Masahiro Kagawa and Keisuke Miyake and Yoshihiro Nishiyama and Yuka Yamamoto and Hirotoshi Shiraishi and Tomotsugu Ichikawa and Takashi Tamiya",
year = "2009",
month = "7",
language = "English",
volume = "37",
pages = "657--664",
journal = "Neurological Surgery",
issn = "0301-2603",
publisher = "Igaku-Shoin Ltd",
number = "7",

}

TY - JOUR

T1 - Use of 11F-fluorothymidine positron emission tomography in brain tumor

AU - Kawai, Nobuyuki

AU - Kagawa, Masahiro

AU - Miyake, Keisuke

AU - Nishiyama, Yoshihiro

AU - Yamamoto, Yuka

AU - Shiraishi, Hirotoshi

AU - Ichikawa, Tomotsugu

AU - Tamiya, Takashi

PY - 2009/7

Y1 - 2009/7

N2 - Positron emission tomography (PET) with [ 18F]-fluoro-3′- deoxy-3′-L-fluoro-thymidine (FLT) provides information on cellular proliferation activity and has been used in malignant brain tumors. FLT-PET is sensitive in detecting malignant glioma due to the very low background uptake in the normal brain tissue. However, the ability to detect low grade glioma and tumor extension appears to be lower for FLT than for methionine (MET). Recent studies have found a correlation between WHO tumor grade and FLT uptake in gliomas. Our recent experience demonstrated a significant difference in the maximum standardized uptake value (SUVmax) of FLT between grade II (0.27±0.06, n=6) and grade IV (2.18±0.93, n=10) glioma (P

AB - Positron emission tomography (PET) with [ 18F]-fluoro-3′- deoxy-3′-L-fluoro-thymidine (FLT) provides information on cellular proliferation activity and has been used in malignant brain tumors. FLT-PET is sensitive in detecting malignant glioma due to the very low background uptake in the normal brain tissue. However, the ability to detect low grade glioma and tumor extension appears to be lower for FLT than for methionine (MET). Recent studies have found a correlation between WHO tumor grade and FLT uptake in gliomas. Our recent experience demonstrated a significant difference in the maximum standardized uptake value (SUVmax) of FLT between grade II (0.27±0.06, n=6) and grade IV (2.18±0.93, n=10) glioma (P

KW - Brain tumor

KW - Cell proliferation

KW - FLT ([ F]-fluoro-3′-deoxy- 3′-L-fluoro-thymidine)

KW - Glioma

KW - Positron emission tomography

UR - http://www.scopus.com/inward/record.url?scp=67749133679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67749133679&partnerID=8YFLogxK

M3 - Article

C2 - 19621774

AN - SCOPUS:67749133679

VL - 37

SP - 657

EP - 664

JO - Neurological Surgery

JF - Neurological Surgery

SN - 0301-2603

IS - 7

ER -